BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會

講師

中裕新藥股份有限公司

 

Company Info

Name /TaiMed Biologics Inc.

Address /No.18, Ln. 15, Shengyi 5th Rd., Zhubei City, Hsinchu County 302, Taiwan (R.O.C.)

Website /www.taimedbiologics.com

Presenter

Name /Jimmy Chang

Title /CEO

Email /cchang@taimedbio.com

Telephone /03-621-2355 #201

Fax /03-668-8929

Mobile /

Company Type

Biotechnology,Pharmaceutical,Others:CDMO/CMO

About the Company

TaiMed Biologics is a developer, manufacturer, and CDMO service provider for mAb drugs. We seek out-licensing opportunities for TROGARZO® (for multidrug-resistant HIV-1 infected patients) and TMB-365/380 combination (for suppressed HIV-1 infected patients). With our extensive expertise and vast experience, we offer the development of upstream/downstream processes, analytical method/formulation development and validation as well as the cGMP manufacturing of biologics.

Brief Description of main products or services

 

  1. TaiMed Biologics was founded in 2007 and has devoted itself as a leading biopharmaceutical developer and manufacturer of innovative biologics drugs. TaiMed has developed a first-in-class anti-HIV antibody-drug ibalizumab (Trogarzo®) which the US FDA and EMA approved in 2018 and 2019, respectively.
  2. TaiMed developed multiple novels long-acting anti-HIV monoclonal antibodies and actively seek out-licensing arrangements and strategic partnerships with international specialty pharmaceutical companies focused on marketing anti-HIV pharmaceuticals.
    • Ibalizumab (TMB-355) Intravenous Infusion - Market
      Ibalizumab (TMB-355) Intravenous Push - NDA / BL
      Ibalizumab (TMB-355) Intramuscular Injection - Phase Ⅲ Studies
    • TMB-365 - PhaseⅠStudies
    • TMB-380 (VRC07-523LS) - PhaseⅠStudies
    • TMB-365/TMB-380 (TMB-365 and TMB-380 combination) - Phase Ⅱ Studies
  3. Leveraging our experience developing Trogarzo® and other novel, long-acting anti-HIV monoclonal antibodies in the pipeline, TaiMed has also become a Contract Development and Manufacturing Organization (CDMO) offering manufacturing solutions that will enable partners to discover, develop and manufacture biologics from the bench to market. We strive to ensure that our clients’ projects are treated as our own with the same high standards with respect to quality, cost, and logistical requirements.
    • cGMP Manufacturing
    • Process Development
    • Analysis and Analytical Method Development
    • Formulation Development
    • Regulatory Affairs

Contact Person

Name /Kit Lin/ CDMO Project Manager

Email /klin@taimedbio.com

Phone /+886-3-621-2355